Seegene Inc
Contact

High specificity & sensitivity

Seegene's products using original technologies provide exceptional performance

Clinically validated by national authorities

Assessed from the 2013 and 2014 HPV LabNet international proficiency studies :
Continuing global improvement in human papillomavirus DNA genotyping services

In 2014, 86/145 datasets (59%) that typed for at least one HPV type were 100% proficient for the types detected by the test. Of these, 32 datasets identified the content of all samples, including the samples with copy number amounts that were lower than required for proficiency.

Reference : Eklund C. et al. (2018) Journal of Clinical Virology, 101:74-84.Reference : Eklund C. et al. (2018) Journal of Clinical Virology, 101:74-84.

Results proved its reliability

Comparison of the fast track diagnostics respiratory 21 and Seegene Allplex™ RP panel assays 26 multiplex polymerase chain reaction assays for the detection of respiratory viruses

Although the performance of the assays were similar, the Seegene assay had the advantage of simultaneous detection of two gene targets for each of the common Influenza A subtypes, improved throughput of 30 samples per run and automated result analysis. Seegene assay had improved multiplexing ability compared to other real-time PCR methods with almost double the throughput compared to the FTD assay.

Reference : Barratt K. et al. (2017) British Journal of Biomedical Science.

Studies showed its exceptional performance

Studies assessing the performance of panels in the diagnosis of bacterial gastrointestinal infection by comparing with routine diagnostic methods.

For bacterial pathogens, Allplex™ was able to detect the organisms grown in culture with high sensitivity and additionally detected several types that could not be detected with conventional culture methods. Overall, Allplex™ had a > 2-fold higher detection rate than the conventional methods.

Reference : Amrud K. et al. (2018) BMC Research Notes, 11:514.